CHIOME BIOSCIENCE INC

Chiome Bioscience (4583.T) surged 2.22% today, trading at ¥92—market cap ¥7.5B—while its ADLib monoclonal antibody platform targets liver cancer and TROP‑2 therapies.

Chiome Bioscience shares dip 1.1%, trading around JPY 92 on the Tokyo Stock Exchange. Discover its drug‑discovery platform, key antibody candidates, and latest market moves.